Efficacy of Acapella on Spirometry Measures in Patients With Bronchiectasis
- Conditions
- Bronchiectasis
- Interventions
- Device: Acapella deviceOther: Only routine chest physical therapy program
- Registration Number
- NCT05838144
- Lead Sponsor
- South Valley University
- Brief Summary
1. Acapella group. Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program .
2. Only routine physical therapy program group ( control group). Will only take medications and routine chest physical therapy program.
- Detailed Description
1. Acapella group.Will use Acapella device for 3 times per day for 15 minutes for 7 days beside medications and routine chest physical therapy program.
2. Only routine physical therapy program group( control group). Will only take medications and routine chest physical therapy program Spirometer measures such as forced vital capacity (FVC) and forced expiratory volume in the first second (FEV1) will be measured for every patient before and after the end of 7 days.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
- bronchiectasis patients.
- Age range between 40 to 55 years old of both gender.
- Cooperative patients.
- Patients with severe cardiac disorders.
- Un controlled hypertensive patients.
- Un controlled diabetic patients.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Acapella Acapella device Will use Acapella device 3 times per day for 15 minutes for 7 days beside medications and routine physical therapy program. Only routine physical therapy program Only routine chest physical therapy program Only they will receive medications and routine physical therapy program. Acapella Only routine chest physical therapy program Will use Acapella device 3 times per day for 15 minutes for 7 days beside medications and routine physical therapy program.
- Primary Outcome Measures
Name Time Method Spirometry measures 7 days FVC, FEV1
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Shymaa yussuf abo zaid
🇪🇬Cairo, Egypt